InvestorsHub Logo
Followers 7
Posts 1011
Boards Moderated 0
Alias Born 07/06/2018

Re: rrao11 post# 37245

Friday, 08/06/2021 1:01:48 PM

Friday, August 06, 2021 1:01:48 PM

Post# of 65779
And I love CEO’s take on seeking alpha this morning:

In laying out plans for funding the next phase of development for the company’s potential COVID-19 therapy JadiCell, Timothy Dixon CEO of Therapeutic Solutions (OTCPK:TSOI -11.1%) says the dilution of share ownership is out of the question.
In a blog post on Friday, Dixon wrote “its not even on my mind today (dilution),” as the company attempts to seek government funding for further clinical development of JadiCell which has received FDA clearance to start a Phase 3 pivotal trial to treat COVID-linked lung failure.
The CEO said the company targets emergency use authorizations for the treatment not only in the U.S. but also overseas.
“One EUA deal and the rest will fall like domino's and we will serve humanity and we will serve you,” he added.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent TSOI News